Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More 12/19/14 Boston
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
At ASH, Sunesis Dices Data to Argue For “Failed” Leukemia Drug 12/07/14 San Francisco
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials 12/07/14 Boston
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
Déjà Vu for Agios as Second Drug Shines in Small Blood Cancer Study 11/18/14 Boston
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
ARCH Venture Exploits IPO Window To Raise $400M Fund, Its Eighth 08/27/14 Seattle
Coelacanths And Other IPO Thoughts Before The Autumn Markets Return 08/26/14 National
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
Two San Francisco Startups Sharing In Third Rock’s Rich Third Fund 04/24/14 San Francisco
East Coast Biotech Roundup: Agios, Spero, Cerulean, & More 04/11/14 Boston
Agios Taps Wall Street Off Early Data, Aims For $75M 04/10/14 Boston
Agios’s Blood Cancer Drug Shines in First Clinical Test 04/06/14 Boston
Backed By a Billionaire, Berg Pharma Aims to Speed Drugmaking 04/02/14 Boston
Calithera Targets Otherworldly Metabolism of Tumor Cells 03/18/14 San Francisco
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
Xconomy Boston’s Top 10 Stories of Q4: Editor’s Picks 12/30/13 Boston
East Coast Biotech Roundup: ASH, Proteostasis, Retrophin, & More 12/13/13 Boston
East Coast Biotech Roundup: Juno, Editas, Celgene, & More 12/06/13 Boston
Celgene Plunks Down $177M Upfront for OncoMed’s Stem Cell Drugs 12/03/13 San Francisco
3 Life Sciences Companies That Are Built to Last 12/02/13 National
Calithera BioSciences Nabs $35M for Cancer Drugs 10/29/13 San Francisco
East Coast Biotech Roundup: Schenkein, PureTech/JDRF, Sage, & More 10/18/13 Boston
Sage Therapeutics Nabs $20M Series B From Third Rock, Arch 10/16/13 Boston
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech 10/16/13 Boston
East Coast Life Sciences Roundup: Foundation, Ophthotech, Sato, & More 09/27/13 Boston
Page 1 of 3 next page »